Table 2.

Genotypic and allelic distribution of the P2Y12R gene between all patients and controls

SNP	Genetic model	Genotype/allele	Cases	Controls	OR	95% CI	p value
rs1491974	Codominant	AA vs. AG vs. GG	27 (15.3%)/88 (50.0%)/61 (34.7%)	14 (28.0%)/26 (52.0%)/10 (20.0%)	-	-	0.047*
	Allele contrast	A vs. G	142 (40.3%)/210 (59.7%)	54 (54.0%)/46 (46.0%)	0.576	0.368–0.901	0.015*
	Dominant	GG vs. AG+AA	61 (34.7%)/115 (65.3%)	10 (20.0%)/40 (80.0%)	2.122	0.993–4.534	0.049*
	Recessive	AG+GG vs. AA	149 (84.7%)/27 (15.3%)	36 (72.0%)/14 (28.0%)	2.146	1.023–4.503	0.040*
	Overdominant	AA+GG vs. AG	88 (50.0%)/88 (50.0%)	24 (48.0%)/26 (52.0%)	1.083	0.578–2.031	0.803
rs6798347	Codominant	AA vs. AG vs. GG	7 (4.0%)/61 (34.6%)/108 (61.4%)	6 (12.0%)/19 (38.0%)/25 (50.0%)	-	-	0.069
	Allele contrast	A vs. G	75 (21.3%)/277 (78.7%)	31 (31.0%)/69 (69.0%)	0.603	0.367–0.988	0.043*
	Dominant	GG vs. AG+AA	108 (61.4%)/68 (38.6%)	25 (50.0%)/25 (50.0%)	1.588	0.844–2.988	0.150
	Recessive	AG+GG vs. AA	169 (96.0%)/7 (4.0%)	44 (88.0%)/6 (12.0%)	3.292	1.053–10.292	0.032*
	Overdominant	AA+GG vs. AG	115 (65.4%)/61 (34.6%)	31 (62.0%)/19 (38.0%)	1.155	0.603–2.213	0.663

CI, confidence interval; OR, odds ratio

^*p<0.05